PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34189538-2	2021	We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial.	azd1222	59-66	CD4 molecule	Homo sapiens	17-20	
34189538-3	2021	Total spike-specific CD4+ T cell helper type 1 (Th1) and CD8+ T-cell responses were significantly increased in AZD1222-vaccinated adults of all ages following two doses of AZD1222.	azd1222	111-118	CD4 molecule	Homo sapiens	21-24	
34189538-3	2021	Total spike-specific CD4+ T cell helper type 1 (Th1) and CD8+ T-cell responses were significantly increased in AZD1222-vaccinated adults of all ages following two doses of AZD1222.	azd1222	172-179	CD4 molecule	Homo sapiens	21-24	
34189538-6	2021	T-cell receptor (TCR) beta sequences from vaccinated participants mapped against TCR sequences known to react to SARS-CoV-2 revealed substantial breadth and depth across the SARS-CoV-2 spike protein for the AZD1222-induced CD4+ and CD8+ T-cell responses.	azd1222	207-214	CD4 molecule	Homo sapiens	223-226	
34189538-7	2021	Overall, AZD1222 vaccination induced a robust, polyfunctional Th1-dominated T-cell response, with broad CD4+ and CD8+ T-cell coverage across the SARS-CoV-2 spike protein.	azd1222	9-16	CD4 molecule	Homo sapiens	104-107	
34189538-8	2021	One Sentence Summary: Polyfunctional CD4+ and CD8+ T-cell responses are elicited against the SARS-CoV-2 spike protein following vaccination with AZD1222.	azd1222	145-152	CD4 molecule	Homo sapiens	37-40